James Lancaster

James Lancaster
James Y. Lancaster, Managing Director VIC Texas Branch, CEO of Tesseract Structural Innovations and CEO of Solenic Medical Inc, is a versatile and innovative technology executive and with over 25 years of experience across multiple industries. Mr. Lancaster holds a BBA from Texas A&M and an MBA from the University of Texas at Austin.
Find me on:

Recent Posts

Enjoy The Ride: Inside an Automotive Startup

Startups are known to be roller coaster rides, but what do you get when you launch an automotive industry startup? A really wild ride! The past year or so has indeed been a wild ride since I took over as CEO of...

Failing to fundraise can be the downfall of startups

Startups are pulling outsized financing rounds and debt acquisitions at an unprecedented rate despite the high 80 percent failure rate of startups overall. Among the three primary reasons why startups tend to fail,...

Houston Innovation Map: 3 Houston Innovators to Know This Week

James Y. Lancaster, Texas Branch Manager Of VIC Technology Venture Development Takes University-Founded Research Innovations To The Marketplace. An Arkansas-based technology venture development firm had its eyes on...

VIC Highlighted by Houston Innovation Map

Exclusive: Out-Of-State Venture Firm Specializing In Research-Based Startups Expands Into Houston. For an Arkansas-based technology venture development firm that focuses on research-based companies coming out of...

FEATURED RESOURCES

News
VIC Technology Venture Development Forms New Portfolio Company: Neurexis Therapeutics
Case Study
The Emerging Remote Workplace: Digital Best Practices for Investor Groups
Reports
VIC 2019 Annual Report
White Paper
Accessing Innovation Directly from the Source - Growing Trends in Venture Capital Company Formation
News
VIC Portfolio Companies and Pipeline Technologies with Pandemic Impact
Interview
An Interview with Nichole Mercier at Washington University
White Paper
Sourcing Quality Innovation Beyond the VC Hot Zones
Case Study
Behind the Curtain: Opportunity Assessment at VIC Technology Venture Development
White Paper
New Paradigms of Life Science Investing
Interview
Behind the Curtain with Biolocity | Guiding Medical Innovations to Market
News
VIC Technology Venture Development Forms New Portfolio Company: Filtravate
White Paper
Life Science Impact Investing and the Physician Entrepreneur
From The Corner Office
SFC Fluidics Nears FDA Submission